Dec
10,
2010

New Drugs to Combat Breast Cancer

Johns Hopkins Kimmel Cancer Center is currently testing three new drugs meant to combat so-called triple negative breast cancers. Triple negative breast cancer refers to when woman lack estrogen, progesterone and human epidermal growth factor 2 ( also known as the three hormone receptors). The first drug, called Entinostat, claims to "blocks an enzyme that unfolds DNA, providing regulatory molecules access to genes within and also reactivates a gene called retinoic acid receptor-beta". The next drug called All Trans Retinoic Acid "binds a protein made by the reactivated RARβ gene". It is said that these two drugs combined can stop cancer growth in its tracks. They are hoping to start clinical trials next year. 

0 comments:

 


Pill Pusher - Templates Novo Blogger 2008